Emergent autoimmunity in graft-versus-host disease.
Donor T-cell recognition of host alloantigens presented by host antigen-presenting cells (APCs) is necessary for the induction of graft-versus-host disease (GVHD), but whether direct alloreactivity is sufficient for the propagation of GVHD is unknown. In this study, we demonstrate that GVHD cannot be effectively propagated through the direct pathway of allorecognition. Rather, donor T-cell recognition of antigens through the indirect pathway is necessary for the perpetuation of GVHD. Furthermore, GVHD results in the breaking of self tolerance, resulting in the emergence of donor T cells that can cause autoimmune disease in syngeneic recipients. Notably, GVHD-induced autoreactivity is donor APC dependent, transferable into secondary hosts, and involves cells of the innate immune system. These results indicate that donor T-cell--mediated pathologic damage during GVHD becomes donor APC dependent and provide a mechanistic explanation for the long-standing observation that GVHD is associated with autoimmune clinical manifestations.
Tivol
Elizabeth
E
Bone Marrow Transplant Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Komorowski
Richard
R
Drobyski
William R
WR
D019264:Adoptive Transfer; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D015551:Autoimmunity; D016026:Bone Marrow Transplantation / Q000379:methods*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D049109:Cell Proliferation; D002469:Cell Separation; D046528:Chimerism; D003092:Colitis / Q000276:immunology; D005434:Flow Cytometry; D006086:Graft vs Host Disease / Q000276:immunology* / Q000628:therapy*; D006098:Granulocytes / Q000276:immunology; D007107:Immune System; D007108:Immune Tolerance; D007150:Immunohistochemistry; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
J Exp Med. 1993 Jul 1;178(1):237-44
8100269
J Exp Med. 1992 Jan 1;175(1):305-8
1730925
Cell. 1993 Oct 22;75(2):253-61
8402910
Curr Opin Immunol. 1993 Oct;5(5):800-3
8240743
Int Immunol. 1993 Nov;5(11):1461-71
7903159
J Exp Med. 1994 Feb 1;179(2):589-600
7905019
J Immunol. 1994 Feb 15;152(4):1609-17
7907102
J Immunol. 1994 Apr 1;152(7):3685-92
8144943
Bone Marrow Transplant. 1994 Oct;14(4):525-33
7858527
Science. 1995 Jun 9;268(5216):1472-6
7770771
Nature. 1998 Mar 5;392(6671):86-9
9510252
J Immunol. 1997 Dec 1;159(11):5391-9
9548479
Transplantation. 2000 Feb 15;69(3):446-9
10706060
Blood. 2000 Jun 15;95(12):3832-9
10845917
Blood. 2002 Feb 15;99(4):1442-8
11830498
Annu Rev Immunol. 2002;20:495-549
11861611
J Immunol. 2002 Aug 1;169(3):1626-33
12133993
J Immunol. 2002 Dec 15;169(12):7111-8
12471148
Transplantation. 2003 Jan 27;75(2):221-5
12548127
Blood. 2003 Jul 15;102(2):429-35
12663438
Hematol Oncol. 2003 Dec;21(4):149-61
14735553
J Exp Med. 2004 Feb 2;199(3):323-35
14744995
J Exp Med. 2004 May 3;199(9):1285-91
15117972
Br J Haematol. 2004 May;125(4):435-54
15142114
Nat Med. 2004 Sep;10(9):987-92
15286785
Br J Haematol. 1987 May;66(1):45-7
3297128
Cell Immunol. 1987 Oct 15;109(2):429-36
2959376
Transplantation. 1988 Aug;46(2):238-40
3043780
Proc Natl Acad Sci U S A. 1990 Aug;87(16):6301-5
2117278
J Immunol. 1992 Jan 1;148(1):35-40
1530797
Blood. 2004 Oct 1;104(7):2187-93
15172973
J Clin Invest. 2004 Oct;114(7):979-87
15467837
Adv Immunol. 1976;22:119-221
56872
J Immunol. 1986 May 15;136(10):3543-8
2871104
J Immunol. 1986 May 15;136(10):3549-52
3486213
J Exp Med. 1998 Jul 20;188(2):387-92
9670050
J Immunol. 1998 Nov 1;161(9):4467-71
9794367
Bone Marrow Transplant. 1998 Nov;22(9):873-81
9827815
Blood. 1999 Jul 15;94(2):390-400
10397705
Science. 1999 Jul 16;285(5426):412-5
10411505
Blood. 1999 Aug 1;94(3):932-9
10419884
Blood. 1999 Sep 1;94(5):1803-13
10477707
J Exp Med. 1993 Sep 1;178(3):805-14
8394404